Regulations.gov document
Draft Guidance for Industry on Best Practices in Developing Proprietary Names for Drugs
Other · FDA-2014-D-0622 · posted May 29, 2014
Key facts
| Document ID | FDA-2014-D-0622-0002 |
|---|---|
| Title | Draft Guidance for Industry on Best Practices in Developing Proprietary Names for Drugs |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2014-D-0622 |
| Posted | May 29, 2014 |
| Comment period opens | May 29, 2014 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: